Curative's lead program centers on a topical metformin eye drop formulation for treating age-related macular degeneration (AMD), geographical atrophy, and other degenerative eye conditions. The company also maintains programs in infectious disease and neuro-oncology, with recent efforts toward OTCQB uplisting and capital structure strengthening through strategic initiatives.
Cyborg Score Rationale
As a micro-cap development-stage biomedical company trading at $0.01 per share with an $8.81 million market cap, Curative faces significant execution risk. Recent reverse stock split (1-for-150) and need for capital raises indicate financial constraints. Limited revenue-generating operations and dependence on successful clinical trials create substantial uncertainty.
Top Insights
Exclusive NIH license for metformin-based eye drop formulation addresses unmet needs in AMD and geographic atrophy
Successfully completed IND-enabling toxicology studies as of January 2023, positioning for IND application submission
Recent 1-for-150 reverse stock split (March 2026) and capital strengthening efforts suggest transition toward OTCQB uplisting
Multi-program pipeline across degenerative eye disease, infectious disease, and neuro-oncology provides diversification but strains limited resources
Named Competitors
Ionis Pharmaceuticals — Develops RNA therapeutics for retinal diseases including geographic atrophy
Genentech/Roche — Pursuing complement inhibition and anti-VEGF approaches for AMD treatment
Apellis Pharmaceuticals — Complement-targeted therapies for age-related macular degeneration
Recent Developments
(March 2026) Announced 1-for-150 reverse stock split and strategic progress toward OTCQB uplisting
(March 2026) Capital structure strengthening initiatives and engagement of strategic advisors
(January 2023) Completed IND-enabling tolerance and toxicology studies for metformin eye drop formulation
Open the full interactive Curative Biotechnology Inc report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.